SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces
Investigation of Young Innovations, Inc. (YDNT), Peregrine
Pharmaceuticals, Inc. (PPHM) and Health Management Associates, Inc.
(HMA)
NEW YORK, Dec. 4, 2012 /PRNewswire/ --
Young Innovations, Inc.
Levi & Korsinsky is
investigating the Board of Directors of Young Innovations, Inc.
(NasdaqGS: YDNT) for possible breaches of fiduciary duty and other
violations of state law in connection with the sale of the Company
to an affiliate of Linden Capital Partners for $39.50 per share. Young Innovations stock traded
above the offer price as recently as September 27, 2012.
Click here to learn more about the investigation:
http://zlk.9nl.com/young-innovations-ydnt/, or call:
877-363-5972.
Peregrine Pharmaceuticals, Inc.
Levi & Korsinsky
is investigating potential claims on behalf of purchasers of
Peregrine Pharmaceuticals, Inc. (NasdaqCM: PPHM) securities
concerning possible breaches of fiduciary duty in connection with
the disclosure of the discovery of major discrepancies in the
treatment group of its Bavituxmab Phase II Second-Line Non-Small
Cell Lung Cancer Trial.
For more information, click here:
http://zlk.9nl.com/peregrine-pharmaceuticals-pphm/.
Health Management Associates, Inc.
Levi &
Korsinsky is investigating potential claims on behalf of purchasers
of Health Management Associates, Inc. (NYSE: HMA) securities
concerning possible breaches of fiduciary duty.
For more information, click here:
http://zlk.9nl.com/health-management-hma/.
On August 3, 2011, the Company
announced that the U.S. Department of Health and Human Services
(DHHS) had issued a subpoena requesting information concerning
Health Management's physician referrals. As a result, shares in the
Company's common stock dropped by $0.80, closing at $7.97 per share. Five months later, on
January 9, 2012, an analyst from CRT
Capital Group reported a lawsuit had been filed against the Company
under Florida's Private Sector
Whistleblower's Act by its former compliance director, Paul Meyer. Meyer alleges he was unlawfully
terminated after reporting what he believed to be Medicare fraud,
which also included fraudulent billing. Health Management's common
stock fell yet again $0.53, dropping
from $7.49 to $6.96 per share.
Levi & Korsinsky is a national firm with offices in
New York and Washington D.C.
The firm has extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors
throughout the nation in securities and shareholder lawsuits.
Attorney advertising. Prior results do not guarantee similar
outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph Levi, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (866) 367-6510
www.zlk.com
(Logo:
http://photos.prnewswire.com/prnh/20120409/MM84375LOGO)
SOURCE Levi & Korsinsky, LLP